Martino Pedrani

12PUBLICATIONS
63CO-AUTHORS
Predictive and prognostic markersMedical mycologyToxicology (incl. clinical toxicology)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 15, 2026
Intratumoral Human Papillomavirus in Advanced Prostate Cancer: Systematic Review, Meta-Analysis, and Real-World Evidence from the Largest Cohort to Date.

|Sep 10, 2026
Commensal Nakaseomyces glabratus migrates into prostate tumors to accelerate cancer progression.

|Aug 27, 2026
Imaging and Clinical Correlates of [177Lu]Lu-PSMA PET-Defined Eligibility in De Novo Metastatic Prostate Cancer.

|Jul 29, 2026
DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Jan 10, 2026
ChronoimmunoTOX: A Single-Institution Retrospective Study on How the Time of Administration Impacts Immune Checkpoint Inhibitor Efficacy and Toxicity in Melanoma.

Alessandro Nepote, Gilles Burghgraeve, Martino Pedrani

Pageof 2

Frequent Collaborators

8 joint publications

Ricardo Pereira Mestre

6 joint publications

Giuseppe Salfi

6 joint publications

Ursula Vogl

5 joint publications

Silke Gillessen